tiprankstipranks
Springworks Therapeutics (SWTX)
NASDAQ:SWTX
US Market

Springworks Therapeutics (SWTX) Financial Statements

285 Followers

Springworks Therapeutics Financial Overview

Springworks Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.979; its P/E ratio is -10.10; Springworks Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -79.44M$ -77.92M$ -73.42M$ -78.98M$ -71.74M
EBITDA-$ -77.54M$ -73.17M-$ -71.53M
Net Income Common Stockholders$ -79.44M$ -77.92M$ -73.42M$ -74.18M$ -72.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 422.42M$ 476.71M$ 528.14M$ 592.22M$ 651.94M
Total Assets$ 467.65M$ 517.33M$ 569.20M$ 616.68M$ 681.55M
Total Debt$ 7.33M$ 7.61M$ 7.05M$ 5.25M$ 5.73M
Net Debt$ -415.09M$ -469.10M$ -521.09M$ -586.97M$ -646.21M
Total Liabilities$ 72.75M$ 65.89M$ 62.27M$ 630.27M$ 69.15M
Stockholders Equity$ 394.90M$ 451.42M$ 506.92M$ 558.22M$ 612.40M
Cash Flow-
Free Cash Flow-$ -50.90M$ -64.80M$ -55.96M$ -23.13M
Operating Cash Flow$ -50.46M$ -47.81M$ -61.82M$ -54.20M$ -19.60M
Investing Cash Flow$ 34.60M$ 60.76M$ 98.60M$ -355.01M$ 86.23M
Financing Cash Flow$ -242.00K$ -342.00K$ -1.85M$ -339.77M$ 340.23M
Currency in USD

Springworks Therapeutics Earnings and Revenue History

Springworks Therapeutics Debt to Assets

Springworks Therapeutics Cash Flow

Springworks Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis